Activity Overview
This symposium brings together renowned experts in low-grade serous ovarian cancer (LGSOC) to discuss evidence-based best practices in the histopathologic and immunohistochemical diagnosis of LGSOC. In this educational program, experts review molecular profiling results in the context of targeted therapy eligibility for recurrent LGSOC and discuss strategies for structured pathology reporting and longitudinal molecular retesting to support treatment decisions throughout the disease course.
This educational activity is an archive of the live virtual symposium held on October 5, 2026.
Target Audience
This educational activity is directed toward pathologists, medical oncologists, nurses, nurse practitioners, physician assistants, pharmacists, and other health care professionals involved in the diagnosis and management of LGSOC.
Learning Objectives
Upon successful completion of this activity, you should be better prepared to:
- Apply histopathologic, immunohistochemical, and molecular criteria to accurately distinguish LGSOC from other serous ovarian neoplasms
- Interpret molecular profiling results in the context of targeted therapy eligibility in recurrent LGSOC
- Evaluate strategies for structured pathology reporting and longitudinal molecular retesting that support timely multidisciplinary team treatment decisions across the LGSOC disease course
Teri A. Longacre, MD
Professor of Pathology
Emerita Richard L. Kempson, MD, Endowed Professor of Surgical Pathology
Stanford Medicine and Stanford Cancer Institute
Stanford, CA
Disclosures: Advisor, Consultant, Fee-for-Service Recipient: Verastem Oncology
Oliver Dorigo, MD, PhD
Mary Lake Polan Professor
Stanford University School of Medicine
Director, Division of Gynecologic Oncology
Department of Obstetrics and Gynecology
Co-Director, Stanford Women’s Cancer Center
Stanford Center for Academic Medicine
Palo Alto, CA
Disclosures: Advisor, Consultant, Fee-for-service Recipient: Corcept Therapeutics, Immatics, Lilly; Grant/Research Funding: A2 Biotherapeutics, AstraZeneca, Genentech, Pheast Therapeutics, TORL BioTherapeutics
Pei Hui, MD, PhD
Professor of Pathology, Obstetrics, Gynecology, and Reproductive Sciences
Director, Center for the Precision Medicine of Trophoblastic Disease
Yale University School of Medicine
New Haven, CT
Disclosures: Advisor, Consultant, Fee-for-Service Recipient: AstraZeneca, PRIME Oncology, Verastem Oncology
The staff of Physicians’ Education Resource®, LLC have no relevant financial relationships with ineligible companies.
PER® mitigated all conflicts of interest for faculty, staff, and planners prior to the start of this activity by using a multistep process.
Off-Label Disclosure and Disclaimer
This accredited continuing education activity was planned in accordance with the ACCME Standards for Integrity and Independence to ensure balance, objectivity, independence, and scientific rigor. Faculty were instructed to use generic names when possible and to base recommendations on the best available evidence. Proprietary product names may be referenced in clinical discussion for educational purposes only and do not imply endorsement.
This activity may include discussion of investigational, unapproved, or off‑label uses of drugs or devices. Learners are advised to consult prescribing information for products discussed. Content is provided for educational purposes only and is not a substitute for the independent clinical judgment of a health care professional. Learners are encouraged to critically evaluate the information presented and apply their own clinical judgment.
The views expressed are those of the individual faculty members and do not necessarily reflect the views of the accredited provider or any entity providing commercial support.
This activity may have used AI-assisted tools to support educational development. All content was reviewed and approved by qualified faculty or planners. The accredited provider retains full responsibility for accuracy, balance, and independence.
GET STARTED WITH THIS PROGRAM:
Register now to gain access to this program.
Create AccountAlready Registered? Login Here